微信直播

AME新书《肝移植研究进展》译者招募

Published at: 2015年第1卷第S1期

关键词:

自1963年,现代肝移植之父美国医生Starzl施行世界上第1 例人体原位肝移植以来,历经40余年的蓬勃发展,肝移植已在全世界步入成熟时期。迄今全世界已累积实施肝移植手术超过10万余例,每年以8000-10000例次的速度前进。与国外相比,我国的肝移植起步较晚。1977年我国开展了人体肝移植的尝试,从此揭开了我国临床肝移植的序幕。随着经验的积累,尤其是近10年的飞速发展,我国的肝移植手术已跻身于国际先进行列。截止2011年10月,全国累计施行肝移植手术约20900例,术后疗效已接近国际先进水平。

近年来,随着外科技术的不断发展、新型免疫抑制剂的应用和临床经验的不断积累,肝移植围手术期并发症和死亡率有了显著下降,术后存活率和存活时间也不断提高。因此,肝脏病变所引起的症状导致患者的生存质量严重下降时,也成为肝移植的主要适应症之一。为进一步分析肝移植的现状,探究肝移植的前沿技术、适应症、围手术期管理等相关进展,AME出版社特邀请上海复旦大学附属中山医院院长的樊嘉教授与德国Department of General and Transplant Surgery, University Hospital Tübingen的Silvio Nadalin教授、英国Institute of Liver Studies, King’s College Hospital 的Nigel Heaton教授共同担任主编出版了英文专著Proceeding in Liver Transplantation

本书共分8个部分,全面阐述了国内外肝移植的现状及前瞻性研究、当前手术技术等前沿知识,也指出了肝移植未来的前景,更详细探讨了小儿肝移植的治疗方法,包括肝移植等待期和围手术期等术前、术中和术后的症状和管理,同时对肝移植的术后护理和预防提供了一些建议。本书希望能给广大临床工作者和读者带来新的知识并从多方面获益。AME将同步出版本书的中文版《肝移植研究进展》,现诚邀国内外该领域优秀医学工作者参与本书的翻译工作!

此专题待翻译文章目录如下,欢迎各位认领:

编号

文章题目

1

A review of current status of living donor liver transplantation

2

Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report

3

Living donor liver transplantation in Egypt

4

Living donor liver transplantation in India

5

Living donor liver transplantation in the USA

6

Living donor liver transplantation in Europe

7

Living donor liver transplantation in Brazil—current state

8

Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital

9

Living donor liver transplantation in Taiwan—challenges beyond surgery

10

Living donor liver transplantation for hepatocellular carcinoma achieves better outcomes

11

Living donor liver transplantation: where do we stand and where are we going?

12

Right lobe living-donor hepatectomy—the Toronto approach, tips and tricks

13

The evolution of anterior sector venous drainage in right lobe living donor liver transplantation: does one technique fit all?

14

Liver transplantation in a patient with complex anomaly of the inferior vena cava

15

Is really full right full left split liver transplantation a valuable tool to increase organ availability?

16

T-tube or no T-tube for bile duct anastomosis in orthotopic liver transplantation

17

Feasible usage of ABO incompatible grafts in living donor liver transplantation

18

Liver transplantation for hepatocellular carcinoma

19

Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation

20

Liver transplantation for unresectable colorectal liver metastasis

21

The multiple aspects of liver transplantation for hepatocellular carcinoma: comments on the recommendations from the consensus conference

22

Liver transplantation for small hepatocellular carcinoma

23

Liver transplantation for hepatocellular carcinoma: are international guidelines possible?

24

Indications for living donor liver transplantation in patients with hepatocellular carcinoma

25

Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma

26

Liver transplantation for hepatocellular carcinoma from living-donor vs. deceased donor

27

Can Milan criteria be expanded effectively for liver transplantation in patients with HCC?

28

Influence on the other patients in the waiting list when expanding the Milan criteria

29

Pediatric liver transplantation for hepatoblastoma

30

Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation

31

The management of perioperative nutrition in patients with end stage liver disease undergoing liver transplantation

32

Role of positron emission tomography/computed tomography in living donor liver transplantation for hepatocellular carcinoma

33

Significance of 99mTc-GSA liver scintigraphy in liver surgery and transplantation

34

Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence

35

Neoadjuvant chemoradiation followed by orthotopic liver transplantation in cholangiocarcinomas: the emory experience

认领方法:

  1. 下载译者报名表(http://rlxt.amegroups.cn/#notices/9),填写完毕后发送到:rlxt@amegroups.com

  2. 编辑部会综合选择最匹配的专家参与翻译,并给符合要求的专家注册系统账号和获取稿件等信息;

  3. 每位会员/译者认领的书籍和文章均不得超过3本/3篇,编辑部将会对超出译者做出适当的调整;

  4. 注:凡是通过编辑部审核并注册系统账号的专家,我们将会在系统委员风采上展示您的个人风采(包括姓名,科室和简介)

  • 认领截止日期:本次认领长期有效,直至认领完毕。

  • 认领成功后,请在认领成功后的三周内将翻译稿及个人简介上传到系统;并发送到rlxt@amegroups.com

凡翻译质量通过审核的译者,可获得:

  1. 每翻译一篇文章,即可获得价值200元人民币的科研时间积分(200快币),可换购各种图书/杂志,免费登录视频数据库ASVIDE,观看手术视频(积分限免)。

  2. 译者署名权。

  3. 中文版出版后,获赠新书一本。

主编风采:

樊嘉

2003年3月至2013年12月任复旦大学附属中山医院副院长,2013年12月始任中山医院院长,并兼任中山医院肝癌研究所常务副所长,教授,博士生导师。现担任中华医学会肿瘤分会主任委员、中国抗癌协会常务理事、上海市医院协会副会长、美国外科医师学院委员(FACS)等学术职务。任Lancet、J Clin Oncol、Oncogene等国际著名杂志审稿人;任《中华消化外科杂志》、《中华肝胆外科杂志》、《中华实验外科杂志》、《中华医学杂志》等20余本杂志副主编或编委。他长期致力于肝肿瘤外科临床诊疗、基础研究及教学工作。个人完成各类复杂肝癌切除手术8000余例,涵盖肝脏外科诸多高难度手术,位居国际前列,治愈了大量肝癌患者。

Silvio Nadalin

Department of General and Transplant Surgery, University Hospital Tübingen, Germany

Nigel Heaton

Institute of Liver Studies, King’s College Hospital, UK. 

Professor Nigel Heaton is a Consultant HPB Surgeon with a specialist interest in split, auxiliary and living related liver transplantation, non-heart beating liver donation along with hepato-biliary surgery and in particular the resection of cholangiocarcionomas. Research interests include metabonomic studies of bile and liver function, ischaemia reperfusion injury after liver transplantation, hepatocellular carcinoma bone marrow micrometastases and islet cell transplantation. Professor Heaton has published over 200 papers on subjects relating to liver transplantation and surgery. He was awarded a personal chair in Liver Transplantation Surgery in 2005 by King’s College Hospital NHS Foundation Trust.

AME科研时间系列图书

AME推出的本系列图书,将临床、科研、人文三者有机结合到一起,像西餐一样,烹调出丰富的味道,搭配出一道精美的佳肴呈现给各位。

comments powered by Disqus

附件